Design and rationale of the PREVENT III clinical trial: Edifoligide for the prevention of infrainguinal vein graft failure

Michael S. Conte, Todd J. Lorenz, Dennis F. Bandyk, Alexander W. Clowes, Gregory L. Moneta, B. Lynn Seely

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Design and rationale of the PREVENT III clinical trial: Edifoligide for the prevention of infrainguinal vein graft failure'. Together they form a unique fingerprint.

Medicine & Life Sciences